ASCENDIS HEALTH LIMITED - Availability Annual Report and Audited Group AFS, No Change Statement and Notice of Annual General Meeting

Availability Annual Report and Audited Group AFS, No Change Statement and Notice of Annual General Meeting

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health” or “the Company”)

Availability of 2020 Integrated Annual Report and Audited Group Annual Financial Statements, No
Change Statement and Notice of Annual General Meeting

1. Availability of 2020 Integrated Annual Report and Audited Annual Financial Statements

    Shareholders are advised that the Ascendis Health 2020 Integrated Annual Report and the audited
    group annual financial statements for the year ended 30 June 2020 for Ascendis Health and its
    subsidiaries (“Audited Group Annual Financial Statements“), are available on the Company’s
    website:

    https://ascendishealth.com/investor-relations/integrated-reports

    or alternatively may be -

          •   obtained from the Company’s registered office: 31 Georgian Crescent East, Bryanston,
              Gauteng, 2191; or
          •   requested by email: mpeo.nkuna@ascendishealth.com

2. No Change Statement

    Except for an update on the Biosciences Disposal as disclosed in section 4 below, the Audited Group
    Annual Financial Statements, on which PricewaterhouseCoopers Inc. express an unmodified opinion,
    do not contain any material changes to the Reviewed Condensed Consolidated Financial Statements
    published on the Stock Exchange News Service of the JSE on 30 September 2020 (“Reviewed
    Financial Statements”).

3. Notice of Annual General Meeting (AGM)

    Shareholders are further advised that the Company’s 8th Annual General Meeting is planned to convene
    on 09:00 on Tuesday, 1 December 2020 and will be conducted entirely by electronic participation as
    contemplated in section 63(2)(a) of the Companies Act, 71 of 2008, as amended (“Companies Act”)
    due to the impact of the COVID-19 pandemic and the restrictions placed on public gatherings.

    The notice of AGM, including a summary of the audited group annual financial statements, will be
    distributed to shareholders on Thursday, 29 October 2020.

    3.1         The salient details of the Annual General Meeting are set out below:

                                                                                                         2020
    Record date for determining those shareholders entitled to receive the                 Friday, 23 October
    notice of AGM
    Last day to trade in order to be eligible to participate in, and vote at the         Tuesday, 17 November
    AGM
    Record date (for voting purposes at the AGM)                                          Friday, 20 November
    Annual General Meeting convened for 09:00                                             Tuesday, 1 December
    It is requested that forms of proxy be lodged, posted or faxed to the Transfer Secretaries,
    Computershare Investor Services Proprietary Limited at –

          •   Rosebank Towers, 1st Floor, 15 Biermann Avenue, Rosebank, 2196, or
          •   Private Bag X9000, Saxonwold, 2132, South Africa; or
          •   by proxy e-mail at proxy@computershare.co.za; or
          •   by fax on +27 11 688 5238,

    to be received by them no later than 09:00 on Friday, 27 November 2020.

    3.2         Electronic participation

    Shareholders or their duly appointed proxy(ies) that wish to participate in the Annual General Meeting
    via electronic communication (“Participant(s)”) must either -

    1. register online using the online registration portal at www.smartagm.co.za; or
    2. apply to Transfer Secretaries, Computershare Investor Services, by sending an email to
       proxy@computershare.co.za so as to be received by Computershare Investor Services by no later
       than 09:00 on Friday, 27 November 2020. Computershare will first validate such requests and
       confirm the identity of the shareholder in terms of section 63(1) of the Companies Act, and, if the
       request is validated, further details on using the electronic communication facility will be provided.
       The Company will inform Participants who notified Computershare Investor Services of their
       intended participation by no later than 09:00 on Monday, 30 November 2020 by email of the relevant
       details through which Participants can participate electronically.

4. Update on Biosciences transaction

Shareholders are referred to Note 30 on page 117 of the Audited Group Annual Financial Statements and
are advised that the proposed Biosciences transaction has been delayed and is expected to be concluded
by December 2020 and not by 30 October 2020 as initially stated in the Reviewed Financial Statements
issued on 30 September 2020.



Bryanston
29 October 2020

Sponsor
Questco Corporate Advisory (Pty) Ltd

Date: 29-10-2020 04:59:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.